Erratum to: Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity

類似資料

• Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
  著者:: Pimentel, M., 等
  出版事項: (2017)
• Antimicrobial Susceptibility of Staphylococcus Isolates from the Skin of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Treated with Repeat Courses of Rifaximin
  著者:: DuPont, Herbert L., 等
  出版事項: (2016)
• Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
  著者:: Lembo, Anthony, 等
  出版事項: (2020)
• Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
  著者:: Cash, Brooks D., 等
  出版事項: (2017)
• Rifaximin: Irritable Bowel Syndrome
  著者:: Generali, Joyce A., 等
  出版事項: (2014)